Recon: FDA vax approval signals looming mandates; Pfizer's $2.3B Trillium takeover
ReconKari Oakes
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsComplianceDiagnostics/IVDsEthicsGlobalHealth Authority meeting and communication strategyMedical DevicesNutritional/Natural HealthPharmaceuticalsProfessional Development/TrainingRegulatory Intelligence/Policy